This week has spurred some major patent announcements from digital health companies Akili Interactive and Sonde Health, which are both affiliated with PureTech Health, a cross disciplinary biopharma company. The two companies announced they have been granted the rights to multiple international digital health patents. Akili revealed they are developing a technology aimed at using neural stimulation to treat cognitive dysfunction and Sonde went public with a patent that uses speech to measure vocal biomarkers for physical or psychological conditions.
